KRUSE BO (EVP, CFO, Secy & Treas.) received a stock award from Y-MABS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/19/2023ACC: 0001104659-23-005026
DirectorOfficer· EVP, CFO, Secy & Treas.
Since Sep 2018
+81.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
81.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.70K
Price / share
—
Trade value
—
% of position
6.5%
1/17/2023
181.08K→192.78K
Total
Net shares
+11.70K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2023 | A · Award | +11.70K | — | — | 6.5% | 181.08K | 192.78K |
| Total | +11.70K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
70.10K shares
Shares
+70.10K
Strike price
4.70
Held after
70.10K
Exercisable
—
1/17/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock70.10K shares | 1/17/2023 | A · Award | +70.10K | 4.70 | — | 70.10K |